Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway

Clusterin is a secretory glycoprotein, which is highly up-regulated in a variety of normal and injury tissues undergoing apoptosis including infarct region of the myocardium. Here, we report that clusterin protects H9c2 cardiomyocytes from H 2 O 2 -induced apoptosis by triggering the activation of A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental & molecular medicine 2011, 43(1), , pp.53-61
Hauptverfasser: Jun, Hyoung-Oh, Kim, Dong-hun, Lee, Sae-Won, Lee, Hye Shin, Seo, Ji Hae, Kim, Jeong Hun, Kim, Jin Hyoung, Yu, Young Suk, Min, Bon Hong, Kim, Kyu-Won
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Clusterin is a secretory glycoprotein, which is highly up-regulated in a variety of normal and injury tissues undergoing apoptosis including infarct region of the myocardium. Here, we report that clusterin protects H9c2 cardiomyocytes from H 2 O 2 -induced apoptosis by triggering the activation of Akt and GSK-3β. Treatment with H 2 O 2 induces apoptosis of H9c2 cells by promoting caspase cleavage and cytochrome c release from mitochondria. However, co-treatment with clusterin reverses the induction of apoptotic signaling by H 2 O 2 , thereby recovers cell viability. The protective effect of clusterin on H 2 O 2 -induced apoptosis is impaired by PI3K inhibitor LY294002, which effectively suppresses clusterin-induced activation of Akt and GSK-3β. In addition, the protective effect of clusterin is independednt on its receptor megalin, because inhibition of megalin has no effect on clusturin-mediated Akt/GSK-3β phosphoylation and H9c2 cell viability. Collectively, these results suggest that clusterin has a role protecting cardiomyocytes from oxidative stress and the Akt/GSK-3β signaling mediates anti-apoptotic effect of clusterin.
ISSN:1226-3613
2092-6413
DOI:10.3858/emm.2011.43.1.006